VistaGen Therapeutics
VTGN
VTGN
33 hedge funds and large institutions have $1.82M invested in VistaGen Therapeutics in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 28 reducing their positions, and 54 closing their positions.
Holders
33
Holders Change
-50
Holders Change %
-60.24%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
28
Closed
54
Calls
$31K
Puts
–
Net Calls
+$31K
Net Calls Change
+$31K
Top Buyers
Top Sellers
1 |
1
BlackRock
New York
|
$196K |
2 |
2
State Street
Boston,
Massachusetts
|
$47.6K |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$419K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$107K |
5 |
5
Northern Trust
Chicago,
Illinois
|
$19.4K |